American Clinical Laboratory Association (Acla)
Trade association for clinical laboratories
Based in DC
🤖
AI Overview
With $2.0M in lobbying spend across 21 quarterly filings, American Clinical Laboratory Association (Acla) is a significant lobbying presence.
$2.0M
Total Lobbying Spend
21
Quarterly Filings
1
Lobbying Firms Used
9
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2020 | $290K |
| 2021 | $400K |
| 2022 | $780K |
| 2023 | $170K |
| 2024 | $230K |
| 2025 | $140K |
Lobbying Firms
COVINGTON & BURLING LLP
What They Lobby For
- Appropriations funding in response to COVID pandemic; Medicare funding
- Appropriations funding in response to COVID pandemic; Medicare funding (*Brendan Parets did not lobby the U.S. Senate*)
- Appropriations funding in response to COVID pandemic; Medicare funding; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128)
- Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Coronavirus impact and response.
- Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); Coronavirus impact and response.
- Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Coronavirus impact and response.
- Policies impacting Medicare coverage and reimbursement for clinical laboratory services; FDA regulation of clinical laboratory services; Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Coronavirus impact and response; FDASLA Act of 2022 (S. 4348); Food and Drug Amendments of 2022 (H.R.7667).
- Verifying Accurate Leading-edge IVCT Development (VALID) Act of 2021 (S. 2209/H.R. 4128); PREVENT Pandemics Act (S. 3799); Consolidated Appropriations Act, 2023 (H.R.2617); Saving Access for Laboratory Services Act (S. 4449/H.R. 8188).
- Food and Drug Administration (FDA) policies related to diagnostics and laboratory regulation; VALID Act (H.R. 2369)
- Discussion of Food and Drug Administration (FDA) policies and authority related to diagnostics and laboratory regulation.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.